These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17339258)

  • 21. Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single-center experience.
    Hayes HM; Dembo LG; Larbalestier R; O'Driscoll G
    Artif Organs; 2010 Sep; 34(9):703-6. PubMed ID: 20883388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.
    Graham JA; Johnson LB; Haddad N; Al-Kawas F; Carroll J; Jha R; Wong J; Maglaris D; Mertens S; Fishbein T
    Am J Surg; 2011 Apr; 201(4):481-5. PubMed ID: 21421102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Octreotide and angiodysplasia].
    Fernández Salazar LI; de la Calle Valverde F; González Hernández JM
    Gastroenterol Hepatol; 2004 Nov; 27(9):558-9. PubMed ID: 15544743
    [No Abstract]   [Full Text] [Related]  

  • 24. Octreotide for Heyde's syndrome: a case report.
    Famularo G; Gasbarrone L; Minisola G
    Presse Med; 2014 Nov; 43(11):1281-3. PubMed ID: 25201596
    [No Abstract]   [Full Text] [Related]  

  • 25. Ranitidine versus ranitidine plus octreotide in the treatment of acute non-variceal upper gastrointestinal bleeding: a prospective randomised study.
    Archimandritis A; Tsirantonaki M; Tryphonos M; Kourtesas D; Sougioultzis S; Papageorgiou A; Tzivras M
    Curr Med Res Opin; 2000; 16(3):178-83. PubMed ID: 11191007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Somatostatin analogues in the treatment of bleeding GI-angiodysplasias].
    Boesby L; Christensen NJ; Kristensen LO
    Ugeskr Laeger; 2008 Mar; 170(11):958. PubMed ID: 18397628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting Release Octreotide for Pediatric Upper Gastrointestinal Bleeding.
    Malla I; López S; Busquet L; Lipsich J; Sierre S; Cervio G; Cuarterolo M
    Rev Chil Pediatr; 2020 Apr; 91(2):251-254. PubMed ID: 32730545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An open trial of octreotide long-acting release in the management of short bowel syndrome.
    Nehra V; Camilleri M; Burton D; Oenning L; Kelly DG
    Am J Gastroenterol; 2001 May; 96(5):1494-8. PubMed ID: 11374688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of octreotide in children with chronic gastrointestinal bleeding.
    Zellos A; Schwarz KB
    J Pediatr Gastroenterol Nutr; 2000 Apr; 30(4):442-6. PubMed ID: 10776959
    [No Abstract]   [Full Text] [Related]  

  • 30. [Management of digestive system hemorrhages].
    Bouix J
    Rev Infirm; 2010 May; (160):43-4. PubMed ID: 20461989
    [No Abstract]   [Full Text] [Related]  

  • 31. A case with intestinal lymphangiectasia successfully treated with slow-release octreotide.
    Filik L; Oguz P; Koksal A; Koklu S; Sahin B
    Dig Liver Dis; 2004 Oct; 36(10):687-90. PubMed ID: 15506669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The potentials for using sandostatin in gastroenterology (a review)].
    Lopatkina TN
    Ter Arkh; 1995; 67(7):66-8. PubMed ID: 7482311
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia.
    Junquera F; Saperas E; Videla S; Feu F; Vilaseca J; Armengol JR; Bordas JM; Piqué JM; Malagelada JR
    Am J Gastroenterol; 2007 Feb; 102(2):254-60. PubMed ID: 17311647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Octreotide for gastrointestinal bleeding of obscure origin in an anticoagulated patient.
    Nordquist LT; Wallach PM
    Dig Dis Sci; 2002 Jul; 47(7):1514-5. PubMed ID: 12141810
    [No Abstract]   [Full Text] [Related]  

  • 35. [MODERN VIEW ON INTENSIVE THERAPY OF GASTRO-INTESTINAL HEMORRHAGE].
    Tutchenko MI; Rudyk DV; Iskra NI; Trofimenko SP; Shchur IV
    Klin Khir; 2015 Oct; (10):11-4. PubMed ID: 26946650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR.
    Toumpanakis C; Garland J; Marelli L; Srirajaskanthan R; Soh J; Davies P; Buscombe J; Caplin ME
    Aliment Pharmacol Ther; 2009 Oct; 30(7):733-40. PubMed ID: 19573169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation.
    Classen CF; Haffner D; Hauenstein C; Wolf R; Kyank U
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients?
    Iannone A; Principi M; Barone M; Losurdo G; Ierardi E; Di Leo A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):373-7. PubMed ID: 27595456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Medical treatment of intestinal hemorrhage in portal hypertension].
    Sauerbruch T; Schiedermaier P
    Dtsch Med Wochenschr; 1998 May; 123(20):633-6. PubMed ID: 9627572
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.
    Penning C; Vecht J; Masclee AA
    Aliment Pharmacol Ther; 2005 Nov; 22(10):963-9. PubMed ID: 16268971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.